Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background:
In recent years, new therapeutic combinations based on immunotherapy provided significant benefits as a first-line treatment for patients with advanced renal cell carcinoma (mRCC).
Objective:
This work aims to address the lack of head-to-head comparisons and the uncertainty of the benefit from immunotherapy-based combinations i...
Alternative Titles
Full title
Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7f88a95dc6f34403b9c22622b09df00e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f88a95dc6f34403b9c22622b09df00e
Other Identifiers
ISSN
1756-2872
E-ISSN
1756-2880
DOI
10.1177/17562872211053189
